BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 30864675)

  • 1. Nur77 inhibition of β-catenin expression mediates Hepatoblastoma progression and enhances cisplatin's therapeutic effect.
    Zhou J; Liu X; Yin H; Zhou Y; Xu Z; Zhou K; Li T; Fang Y; Shen Q
    Gene; 2024 May; 908():148292. PubMed ID: 38369247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A TGF-β-dominant chemoresistant phenotype of hepatoblastoma associated with aflatoxin exposure in children.
    Xiang X; Hao Y; Cheng C; Hu H; Chen H; Tan J; Wang Y; Liu X; Peng B; Liao J; Wang J; Xie Y; Liu J; Chen S; Xu L; Xie W; Xue R; Kuang M; Xu Z; Jiang H; Peng S
    Hepatology; 2024 Mar; 79(3):650-665. PubMed ID: 37459556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD47-Dependent Regulation of Immune Checkpoint Gene Expression and MYCN mRNA Splicing in Murine CD8 and Jurkat T Cells.
    Kaur S; Awad D; Finney RP; Meyer TJ; Singh SP; Cam MC; Karim BO; Warner AC; Roberts DD
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastoma.
    Roehrig A; Hirsch TZ; Pire A; Morcrette G; Gupta B; Marcaillou C; Imbeaud S; Chardot C; Gonzales E; Jacquemin E; Sekiguchi M; Takita J; Nagae G; Hiyama E; Guérin F; Fabre M; Aerts I; Taque S; Laithier V; Branchereau S; Guettier C; Brugières L; Fresneau B; Zucman-Rossi J; Letouzé E
    Nat Commun; 2024 Apr; 15(1):3031. PubMed ID: 38589411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Human Organoid Model of Aggressive Hepatoblastoma for Disease Modeling and Drug Testing.
    Saltsman JA; Hammond WJ; Narayan NJC; Requena D; Gehart H; Lalazar G; LaQuaglia MP; Clevers H; Simon S
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32962010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotypic Characteristics of Hepatoblastoma as Detected by Next Generation Sequencing and Their Correlation With Clinical Efficacy.
    Hu H; Zhang W; Zhi T; Li J; Wen Y; Li F; Mei Y; Huang D
    Front Oncol; 2021; 11():628531. PubMed ID: 34426785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Mechanisms of Hepatoblastoma.
    Zhang Y; Solinas A; Cairo S; Evert M; Chen X; Calvisi DF
    Semin Liver Dis; 2021 Jan; 41(1):28-41. PubMed ID: 33764483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation in Hepatoblastoma-a literature review.
    Shen G; Shen H; Zhang J; Yan Q; Liu H
    Ital J Pediatr; 2020 Aug; 46(1):113. PubMed ID: 32758256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatoblastoma: current knowledge and promises from preclinical studies.
    Calvisi DF; Solinas A
    Transl Gastroenterol Hepatol; 2020; 5():42. PubMed ID: 32632393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo evolved gene product NCYM in the pathogenesis and clinical outcome of human neuroblastomas and other cancers.
    Suenaga Y; Nakatani K; Nakagawara A
    Jpn J Clin Oncol; 2020 Aug; 50(8):839-846. PubMed ID: 32577751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers.
    Wolpaw AJ; Bayliss R; Büchel G; Dang CV; Eilers M; Gustafson WC; Hansen GH; Jura N; Knapp S; Lemmon MA; Levens D; Maris JM; Marmorstein R; Metallo SJ; Park JR; Penn LZ; Rape M; Roussel MF; Shokat KM; Tansey WP; Verba KA; Vos SM; Weiss WA; Wolf E; Mossé YP
    Cancer Res; 2021 Apr; 81(7):1627-1632. PubMed ID: 33509943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting excessive MYCN expression using MLN8237 and JQ1 impairs the growth of hepatoblastoma cells.
    Eberherr C; Beck A; Vokuhl C; Becker K; Häberle B; Von Schweinitz D; Kappler R
    Int J Oncol; 2019 May; 54(5):1853-1863. PubMed ID: 30864675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Killing of Human Neuroblastoma Cells by the Small Molecule JQ1 Occurs in a p53-Dependent Manner.
    Mazar J; Gordon C; Naga V; Westmoreland TJ
    Anticancer Agents Med Chem; 2020; 20(13):1613-1625. PubMed ID: 32329693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYCNOS functions as an antisense RNA regulating MYCN.
    Vadie N; Saayman S; Lenox A; Ackley A; Clemson M; Burdach J; Hart J; Vogt PK; Morris KV
    RNA Biol; 2015; 12(8):893-9. PubMed ID: 26156430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells.
    O'Brien EM; Selfe JL; Martins AS; Walters ZS; Shipley JM
    BMC Cancer; 2018 Feb; 18(1):217. PubMed ID: 29466962
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.